Coronary artery disease is diagnosed through a combination of risk factor assessment, blood tests, and heart imaging, with the specific tests depending on your symptoms and likelihood of having the disease. The process typically starts in a primary care or cardiology office and may progress from simple, non-invasive tests to more detailed imaging or, in some cases, a catheter-based procedure that directly visualizes the arteries.
The Starting Point: Symptoms and Risk Factors
Before ordering any tests, your doctor evaluates the full picture: your symptoms, medical history, family history, and cardiovascular risk factors like high blood pressure, cholesterol levels, smoking status, diabetes, and weight. This initial assessment shapes everything that follows, because the same chest discomfort in a 35-year-old nonsmoker and a 60-year-old with diabetes calls for very different diagnostic approaches.
Doctors often use a standardized risk calculator that estimates your chance of having a cardiovascular event over the next 10 years. These calculators use office-based measurements like blood pressure, cholesterol, age, and sex. The result places you into a risk category (low, borderline, intermediate, or high) that guides how aggressively your doctor pursues further testing. People at low risk are typically managed with lifestyle changes alone, while those at higher risk may need imaging and medication.
For people whose risk falls in the borderline or intermediate range, additional factors can tip the scales. A family history of early heart disease, persistently high LDL cholesterol, chronic kidney disease, or elevated markers of inflammation all raise concern and may push toward more testing.
Why Symptoms Can Be Misleading
Classic coronary artery disease presents as chest pain or pressure during exertion, but many people, particularly women, older adults, and people with diabetes, experience something quite different. Older patients are significantly more likely to report indigestion, abdominal discomfort, nausea, vomiting, or shortness of breath instead of chest pain. Older adults with chronic conditions like prior stroke, COPD, or heart failure are roughly 3.3 times more likely to have these atypical symptoms compared to otherwise healthy older adults.
In younger patients, diabetes and high cholesterol are strong predictors of atypical presentations. This matters because if you or your doctor are only watching for textbook chest pain, the disease can go unrecognized. Unexplained shortness of breath, unusual fatigue with activity, or digestive symptoms that come on with exertion all warrant a closer look in someone with cardiovascular risk factors.
Blood Tests
Your doctor will likely order bloodwork early in the process. This includes cholesterol levels (total, LDL, HDL), triglycerides, blood sugar or hemoglobin A1c (a measure of long-term blood sugar control), and sometimes markers of inflammation. These tests don’t diagnose coronary artery disease directly, but they reveal how much damage your arteries may be accumulating and help calibrate your overall risk. In situations where a heart attack is suspected, a blood test measuring a protein released by damaged heart muscle helps distinguish between stable coronary disease and an acute event.
The Electrocardiogram
An electrocardiogram, or ECG, is often the first heart-specific test. It records the electrical signals traveling through your heart, showing whether the rhythm is steady or irregular and whether parts of the heart muscle aren’t getting enough blood. The test takes a few minutes, involves stickers placed on your chest, and is painless. A resting ECG can reveal evidence of a prior heart attack or ongoing blood flow problems, but it can appear completely normal in someone with significant coronary disease if the heart isn’t under stress at the time.
Stress Tests
Stress testing puts your heart under controlled demand, usually by having you walk on a treadmill or ride a stationary bike, while monitoring your ECG, blood pressure, and symptoms. The goal is to see whether your heart’s blood supply keeps up when it’s working hard.
A basic exercise ECG stress test has a sensitivity of about 68% and specificity of 77% for detecting coronary artery disease. In practical terms, that means it catches roughly two-thirds of people who have the disease and correctly clears about three-quarters of those who don’t. It’s a reasonable first step, but it misses a meaningful number of cases.
Adding imaging to the stress test improves accuracy substantially. When a nuclear perfusion scan is combined with exercise, sensitivity jumps to around 90% and specificity to 93% with current imaging agents. These tests use a small amount of radioactive tracer injected into a vein, which travels to the heart muscle. Areas receiving less blood flow light up differently on the scan, pinpointing where blockages may be limiting supply.
If you can’t exercise adequately (because of joint problems, deconditioning, or other limitations), a medication can be given through an IV to simulate the effect of exercise on the heart. These pharmacological stress tests perform comparably to exercise-based ones, with sensitivity for detecting coronary disease ranging from 89% to 91%. In women, medication-based perfusion imaging is significantly more sensitive than exercise imaging for detecting single-vessel disease.
Coronary Calcium Scoring
A coronary artery calcium scan uses a quick, low-dose CT scan to measure the amount of calcium deposited in the walls of your coronary arteries. Calcium buildup is a direct sign of atherosclerosis, the plaque accumulation that defines coronary artery disease. The result is reported as an Agatston score:
- 0: Very low risk, no detectable calcium
- 1 to 99: Mildly increased risk
- 100 to 299: Moderately increased risk
- 300 or higher: Moderate to severely increased risk
A score of zero is highly reassuring and often means aggressive testing or treatment can be deferred. This test is particularly useful for people in the borderline or intermediate risk range, where the result can clarify whether preventive medication is worthwhile. It does not show whether a specific blockage is limiting blood flow, only that plaque exists.
CT Angiography
Coronary CT angiography (CCTA) takes the calcium scan a step further. It uses contrast dye injected into a vein and a CT scanner to create detailed 3D images of the coronary arteries, showing both the location and severity of any narrowing. Results are reported using a standardized system called CAD-RADS, which ranges from 0 (no plaque or narrowing at all) to 5 (at least one completely blocked artery), based on the most severe narrowing found anywhere in the coronary arteries.
Current guidelines from the American Heart Association and American College of Cardiology recommend imaging for patients with new or persistent stable chest pain. For people with frequent chest pain or severe stress-induced blood flow problems, referral for either CT angiography or an invasive catheter-based angiogram is a reasonable next step. CT angiography has become increasingly popular because it’s non-invasive and provides detailed anatomic information, but it exposes you to some radiation and contrast dye, and it’s less useful in people with very fast or irregular heart rhythms.
Invasive Coronary Angiography
The gold standard for diagnosing coronary artery disease is an invasive coronary angiogram, also called cardiac catheterization. A thin tube is threaded through an artery in the wrist or groin up to the heart, and contrast dye is injected directly into the coronary arteries while X-ray images are captured in real time. This provides the most detailed view of any blockages.
By convention, a narrowing of 50% or more is considered “significant” coronary artery disease. However, the threshold that actually predicts whether a blockage is limiting blood flow and would benefit from treatment is closer to 70%. A 50% narrowing may look notable on the image but often doesn’t restrict blood flow enough to cause symptoms or show up on a stress test.
When a blockage falls in an ambiguous range, doctors can measure pressure across the narrowing during the same procedure. This is called fractional flow reserve, or FFR. A small wire-tipped sensor is advanced past the blockage, and the pressure drop is recorded. An FFR value at or below 0.80 indicates the blockage is hemodynamically significant, meaning it’s actually reducing blood flow enough to matter. Values above 0.80 suggest the narrowing can be safely left alone. This measurement has been shown to be superior to visual assessment of the angiogram alone for deciding whether a blockage needs treatment.
Because catheterization is invasive and carries small risks (bleeding, infection, allergic reaction to dye, and rarely more serious complications), it’s generally reserved for situations where non-invasive tests strongly suggest significant disease, symptoms are severe, or a decision about stenting or bypass surgery needs to be made.
How These Tests Fit Together
The diagnostic process is layered intentionally. Not everyone needs every test. A low-risk person with atypical symptoms might need nothing beyond an ECG and bloodwork. Someone with classic exertional chest pain might go straight to a stress test with imaging. A person with an intermediate calcium score and ongoing symptoms might be referred for CT angiography. And someone with strongly positive non-invasive results, worsening symptoms, or high clinical suspicion moves to catheterization.
The 2023 AHA/ACC guidelines emphasize matching the intensity of testing to the clinical situation. The goal is to identify who has disease severe enough to benefit from treatment while avoiding unnecessary procedures in people whose arteries are clear or whose blockages aren’t flow-limiting. If your doctor recommends a specific test, it’s worth asking what the result would change about your care, since the answer helps you understand where you stand in this diagnostic sequence.